Can You Get Measles Twice in Your Life?

Measles infection almost always confers lifelong immunity, making a second bout extraordinarily rare. The immune response to measles is among the most durable in all of infectious disease, and the virus itself is genetically constrained to a single serotype, meaning new strains cannot easily dodge existing antibodies. Yet “almost always” is not “never.” A small number of documented reinfections exist, certain medical conditions can erase prior immunity, and the distinction between natural infection and vaccination adds a layer of complexity that matters more now than it did a generation ago.

Why One Infection Usually Means Lifelong Protection

When you catch measles, your immune system mounts an aggressive response that leaves a deep and lasting imprint. Antibodies appear within days of the rash, and several types of immune memory persist for decades. A classic study tracking antibody persistence found that measles-specific antibodies were still detectable four to twenty years after infection, with antibodies against the virus’s internal structures dominating the long-term response.¹ This depth of immune memory is why measles has historically been considered a “one and done” infection.

A major reason reinfection stays so rare is that the measles virus has remarkably little room to mutate in ways that matter. Although 24 genotypes have been identified over the years, the surface proteins the immune system targets are tightly constrained. The virus essentially presents the same face to your antibodies regardless of which genotype is circulating, which is why a single vaccine works worldwide and why someone who caught measles decades ago still has protection against modern strains.² Compare that with influenza, which mutates its surface proteins so freely that you need a new shot every year. Measles simply does not have that trick available.

Vaccine-Induced Immunity Is Robust but Not Identical

The measles vaccine is remarkably effective, but the immunity it produces differs from what you get after a full-blown wild infection. An Italian study comparing antibody levels in adults found that people who had recovered from natural measles carried antibody levels roughly three and a half times higher than those who had been vaccinated. The geometric mean titer was about 213 in the naturally infected group versus about 61 in the vaccinated group.³ Both groups had protective levels of antibodies, but the gap is real and becomes relevant over time.

This difference matters because vaccine-induced antibodies can wane. When they drop far enough, a vaccinated person may become susceptible again, a phenomenon known as secondary vaccine failure. This is distinct from primary vaccine failure, where the immune system never responded to the vaccine in the first place. Primary failure accounts for the vast majority of cases where vaccinated people catch measles, but secondary failure is the more interesting problem for the “can you get it twice” question, because it means someone who was once genuinely immune has lost that protection.⁴ Researchers can now distinguish between the two by measuring how tightly antibodies bind to the virus. Loosely binding antibodies suggest the immune system never properly learned to recognize measles, while tightly binding antibodies that have simply declined in quantity point to waning immunity.⁵

When someone with secondary vaccine failure does catch measles, the illness often looks different. In one outbreak investigation, eleven patients with high-avidity antibodies, the hallmark of secondary failure, developed what is called modified measles: a milder version with a lighter rash, lower fever, and less of the classic progression.⁶ Their immune systems still remembered enough to blunt the infection, even if they could not block it entirely.

Documented Reinfection After Natural Measles

True reinfection after confirmed natural measles is among the rarest events in infectious disease, but it has been recorded. In one well-documented case, researchers isolated live measles virus from the urine of a woman who had caught measles naturally as a child roughly fifty years earlier. She showed no symptoms during this second encounter, but her body mounted a clear secondary immune response, with a rise in neutralizing antibody titers confirming that the virus had genuinely re-entered and replicated.⁷ Cases like this are important because they show that “lifelong immunity” does not always mean “complete sterilizing immunity.” Your immune system may not prevent the virus from gaining a brief foothold, but it crushes it before you get sick or become meaningfully contagious.

This is a useful distinction. In virology, there is a difference between protection against disease and protection against any infection at all. Most people who had measles as children are protected against both, but a small number may experience silent, transient reinfection that their immune memory handles quickly. For practical purposes, this kind of reinfection carries little risk either to the person or to those around them.

The Hidden Role of Re-Exposure in Keeping Immunity Strong

Here is something that rarely makes the headlines: for much of human history, people who recovered from measles kept encountering the virus in their communities. Those repeated exposures acted like natural booster shots, topping off antibody levels without causing illness. Research has shown that convalescent patients who were periodically re-exposed to wild measles maintained stable antibody levels, while those living in settings where measles had been eliminated saw their antibodies gradually drift downward.⁸

This creates a paradox for countries that have eliminated measles. The better a nation does at stopping transmission, the fewer opportunities there are for this natural boosting to occur. Australian data have confirmed that measles-specific antibodies decline over time in populations with sustained measles control.⁹ Whether that decline translates into meaningful vulnerability is debated. Antibody levels are only one layer of defense; immune memory cells can often ramp up antibody production quickly when the virus reappears, even if baseline levels have dropped. But the trend is worth watching, especially as global travel keeps reintroducing measles into populations that have not seen it in years.

When the Immune System Loses Its Memory

The most significant way someone could become vulnerable to measles a second time is if their immune system is damaged or reset. Cancer treatment is the clearest example. A study of nearly a thousand cancer patients found that only about three-quarters had protective measles antibodies, compared with the much higher rates you would expect in the general population. Among patients with blood cancers, the figure dropped to roughly 63 percent. And for those who had undergone a stem cell transplant, fewer than half still tested positive for measles antibodies.¹⁰

Stem cell transplantation is an especially dramatic case because it essentially reboots the immune system. Antibodies built up over a lifetime, whether from natural infection or vaccination, can be wiped out. These patients often need to be revaccinated from scratch, as though they were infants encountering the world for the first time. Other immunosuppressive treatments, including certain therapies for autoimmune diseases, can similarly erode measles immunity. For people in these situations, the answer to “can you get measles twice” is an uncomfortable yes.

How Measles in Previously Immune People Behaves Differently

When someone with partial or waning immunity does catch measles, the disease often looks atypical. Atypical measles syndrome was first identified in the 1960s among people who had received an early, inactivated version of the measles vaccine that is no longer used.¹¹ But milder, modified presentations also occur in people with secondary vaccine failure who encounter wild virus today. The rash may be faint or appear in an unusual pattern, the fever tends to be lower, and the whole episode can be brief enough to be mistaken for a mild viral illness.

The good news is that people with modified measles are far less dangerous to others. A review of fourteen studies found that among more than three thousand people exposed to secondary vaccine failure cases, the secondary attack rate ranged from zero to about six percent. Roughly one in ten of those modified cases transmitted the virus at all, producing an effective reproduction number of just 0.063, a tiny fraction of the famously high reproduction number of standard measles.¹² That finding has practical implications for outbreak management: public health teams can reasonably focus containment efforts on unvaccinated contacts rather than chasing down every mildly symptomatic vaccinated person.

Healthcare Workers and the Post-Elimination Reality

Hospitals are one place where even small gaps in immunity can have outsized consequences. A study of measles cases in the post-elimination era found that five out of twenty-two confirmed cases in one outbreak were healthcare workers. Four of those workers had direct contact with measles patients, and none wore N95 respirators during those encounters. Four healthcare workers who had prior evidence of immunity continued working after developing symptoms, exposing over a thousand people, though no transmissions resulted from those exposures.¹³ That last detail is revealing: even among healthcare workers who technically caught measles despite prior immunity, the infections were mild enough and the resulting viral loads low enough that they did not spark further spread.

The lesson from hospital outbreaks is not that healthcare workers are at high risk of true reinfection, but that institutional settings concentrate exposure in ways that test the edges of immunity. When measles is circulating, even a robust immune response gets stress-tested by intense, close-range viral exposure.

The Immune Amnesia Problem

There is an ironic twist to the measles immunity story. While the virus itself provokes one of the strongest immune memories known, the process of infection actively destroys immune memory for other diseases. Measles infects and kills immune cells that carry memories of previous infections, effectively rolling back years of accumulated protection against other pathogens. In animal models, this “immune amnesia” can be severe. Ferrets infected with a measles-related virus lost their pre-existing immunity to rabies vaccine within three weeks, and that immunity never came back during a three-month observation period.¹⁴

Immune amnesia does not make you more likely to get measles a second time, since the measles-specific immune response is being actively reinforced during the very infection that causes the amnesia. But it means that recovering from measles can leave you temporarily vulnerable to a host of other infections you were previously protected against. Studies in human populations have linked measles outbreaks to spikes in deaths from other infectious diseases for two to three years afterward. This is one of the strongest arguments for vaccination: the vaccine triggers measles immunity without the immune amnesia that accompanies natural infection.

Infants and the Maternal Antibody Window

Babies are born with a temporary supply of their mother’s antibodies, including measles antibodies if the mother is immune. But these borrowed antibodies fade over the first months of life, creating a window of vulnerability before the child is old enough to be vaccinated, typically around twelve months. The concentration and persistence of these maternal antibodies differ depending on whether the mother acquired immunity through natural infection or through vaccination.¹⁵ Mothers who had measles themselves tend to pass on higher antibody levels that last longer in the infant, while vaccinated mothers pass on lower levels that wane earlier.

This does not mean the infant “gets measles twice” in the traditional sense, since the initial protection was not their own immune response. But it does mean that in communities where most women of childbearing age were vaccinated rather than naturally infected, infants may lose maternal protection sooner and face a longer unprotected window. As the generation of women who caught measles as children ages out of reproductive years, this shift in maternal antibody quality is likely to become more pronounced.

Does the Virus’s Genetic Stability Guarantee Forever Immunity?

Measles has one serotype, and its surface proteins are under strong evolutionary constraints that limit how much they can change without crippling the virus. This is reassuring, but it raises a fair question: could those constraints ever loosen? Could a measles variant emerge that slips past existing immunity the way new flu strains do every year?

So far, the answer appears to be no. Even across all 24 known genotypes, the proteins the immune system targets remain functionally similar enough that antibodies from one genotype cross-react with another. A Brazilian study found that children vaccinated with the standard vaccine strain still produced neutralizing antibodies effective against the D8 genotype, one of the most globally prevalent wild strains, five to eight years after their second dose. Most of the children also showed cell-mediated immune responses to measles, a second layer of defense that does not depend on antibodies alone.¹⁶ The constraints on measles evolution are structural: the virus uses specific receptor-binding sites that it cannot easily alter without losing its ability to infect cells. As long as that remains true, a single infection or a two-dose vaccine series should continue to provide broad protection.

Vitamin A and Other Nutritional Factors

Vitamin A supplementation has long been recommended during acute measles illness, particularly in malnourished children, because deficiency is associated with more severe disease and higher mortality. But does nutritional status affect the durability of measles immunity after recovery or vaccination? A cross-sectional study of vaccinated children in India found that neither vitamin A deficiency nor body weight status was associated with measles antibody levels or neutralizing antibody titers.¹⁷ In other words, while vitamin A matters enormously during an active infection, it does not appear to determine whether your immune system holds onto measles protection in the years afterward. The fear that malnutrition could cause someone to “lose” their measles immunity and become susceptible again does not have strong support, at least based on humoral markers. Severe immunosuppression from malnutrition is a different story, but garden-variety nutritional variation does not seem to move the needle on long-term measles antibody levels.